GlassScriptPhysician profile
Andrew Koogler
NPI 1851719421
$11,246.27
in general payments reported to CMS, 2019-2025
37 companies · $1,338 in 2025
The $1,338 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,496 · 2020: $824 · 2021: $1,458 · 2022: $1,298 · 2023: $2,791 · 2024: $1,041 · 2025: $1,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,328 · Travel and Lodging: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,328.47 |
| Travel and Lodging | $841.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,226.01 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,594.63 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Relievant Medsystems, INC. | $1,385.90 | 2022-2023 | Intracept |
| Flowonix Medical Incorporated | $589.49 | 2019-2020 | |
| Medtronic, INC. | $530.99 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Ascenda |
| Globus Medical, INC. | $481.59 | 2025 | Senza, Vyrsa V1 |
| Collegium Pharmaceutical, INC. | $355.74 | 2020-2023 | Xtampza |
| Spr Therapeutics, INC | $293.98 | 2020-2025 | Sprint Pns System |
| Foundation Fusion Solutions, LLC | $205.49 | 2020-2022 | |
| Abbvie INC. | $154.71 | 2021-2023 | |
| Nalu Medical, INC. | $150.82 | 2021-2025 | Nalu Neurostimulation System |
| Biohaven Pharmaceuticals, INC. | $148.28 | 2021 | |
| Abbott Laboratories | $146.37 | 2021-2025 | Proclaim, Freestyle Libre 3 |
| Saluda Medical Americas, INC. | $107.82 | 2024-2025 | Evoke |
| Vertos Medical, INC. | $95.30 | 2024 | Mild Device Kit |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $93.88 | 2019 | |
| Fidia Pharma USA INC. | $64.45 | 2024-2025 | Hymovis, Hyalgan, Triluron |
| Si-Bone, INC. | $54.79 | 2024 | |
| Axonics, INC. | $45.79 | 2023-2024 | Axonics |
| Biodelivery Sciences International, INC. | $45.03 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.04 | 2023-2025 | Relistor |
| Pfizer INC. | $40.74 | 2023-2024 | |
| Bioventus LLC | $39.86 | 2021 | |
| Allergan, INC. | $38.30 | 2020 | |
| Painteq LLC | $35.91 | 2024 | Painteq |
| Virtus Pharmaceuticals LLC | $33.33 | 2024 | Levorphanol Tartrate |
| Orexo US, INC. | $29.63 | 2022-2023 | Zubsolv |
| Merz Pharmaceuticals, LLC | $29.03 | 2025 | Xeomin |
| Vertex Pharmaceuticals Incorporated | $26.41 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.17 | 2022 | |
| Braeburn INC. | $24.41 | 2025 | Brixadi |
| Novo Nordisk INC | $24.22 | 2025 | Rybelsus, Ozempic |
| Biotronik Nro, INC. | $22.70 | 2025 | Prospera |
| Amgen INC. | $18.00 | 2021 | |
| Convatec INC. | $16.20 | 2025 | |
| Lilly USA, LLC | $15.52 | 2022 | |
| Baudax Bio INC. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Koogler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.